Skip to main content
Fig. 3 | Health and Quality of Life Outcomes

Fig. 3

From: Biomarkers-based personalized follow-up in chronic heart failure improves patient’s outcomes and reduces care associate cost

Fig. 3

One thousand bootstrap estimates of the differences in mean cost and mean (quality adjusted) survival time between pre- and post-intervention. The cost-effectiveness plane represents the incremental costs and effects of the intervention compared to regular care. The origin represents the comparator treatment, in this case non personalized follow up management. If the new intervention lies to the right of the origin it is more effective (i.e., it has more QALYs than those with regular care), or if it lies to the left of the origin it is less effective. If it lies above the x-axis then it is more costly than B, and vice versa

Back to article page

Health and Quality of Life Outcomes

ISSN: 1477-7525

Contact us